ES2148057A1 - Nuevo uso del diacepam como potenciador del efecto de los inhibidores pde 3 - Google Patents

Nuevo uso del diacepam como potenciador del efecto de los inhibidores pde 3

Info

Publication number
ES2148057A1
ES2148057A1 ES009800004A ES9800004A ES2148057A1 ES 2148057 A1 ES2148057 A1 ES 2148057A1 ES 009800004 A ES009800004 A ES 009800004A ES 9800004 A ES9800004 A ES 9800004A ES 2148057 A1 ES2148057 A1 ES 2148057A1
Authority
ES
Spain
Prior art keywords
diacepam
pde
pharmaceuticals
enhancement
effect consists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES009800004A
Other languages
English (en)
Other versions
ES2148057B1 (es
Inventor
Cascales Jesus Hernandez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universidad de Murcia
Original Assignee
Universidad de Murcia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universidad de Murcia filed Critical Universidad de Murcia
Priority to ES9800004A priority Critical patent/ES2148057B1/es
Publication of ES2148057A1 publication Critical patent/ES2148057A1/es
Application granted granted Critical
Publication of ES2148057B1 publication Critical patent/ES2148057B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Nuevo uso del diacepam como potenciador del efecto de los inhibidores PDE3. El diacepam es útil en la fabricación de fármacos potenciadores del efecto de los inhibidores de la fosfodiesterasa tipo 3 (PDE3). También es útil en la fabricación de fármacos para el tratamiento de pacientes con insuficiencia cardíaca.
ES9800004A 1998-01-05 1998-01-05 Nuevo uso del diacepam como potenciador del efecto de los inhibidores pde 3 Expired - Fee Related ES2148057B1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES9800004A ES2148057B1 (es) 1998-01-05 1998-01-05 Nuevo uso del diacepam como potenciador del efecto de los inhibidores pde 3

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9800004A ES2148057B1 (es) 1998-01-05 1998-01-05 Nuevo uso del diacepam como potenciador del efecto de los inhibidores pde 3

Publications (2)

Publication Number Publication Date
ES2148057A1 true ES2148057A1 (es) 2000-10-01
ES2148057B1 ES2148057B1 (es) 2001-05-16

Family

ID=8302315

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9800004A Expired - Fee Related ES2148057B1 (es) 1998-01-05 1998-01-05 Nuevo uso del diacepam como potenciador del efecto de los inhibidores pde 3

Country Status (1)

Country Link
ES (1) ES2148057B1 (es)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996005839A1 (en) * 1994-08-18 1996-02-29 Merck & Co., Inc. 2,3-dihydro-1-(2,2,2-trifluoroethyl)-2-oxo-5-phenyl-1h-1,4-benzodiazepines
US5706829A (en) * 1996-06-06 1998-01-13 Creighton University Method for treating neurocardiogenic syncope

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996005839A1 (en) * 1994-08-18 1996-02-29 Merck & Co., Inc. 2,3-dihydro-1-(2,2,2-trifluoroethyl)-2-oxo-5-phenyl-1h-1,4-benzodiazepines
US5706829A (en) * 1996-06-06 1998-01-13 Creighton University Method for treating neurocardiogenic syncope

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CAS on line, QUESTEL, AN 083-157882 & Am. J. Vet. Res., Vol. 36, paginas 1203-1206, 1975. "Antiarrhythmic effects of diazepam during coronary artery occlusion in dogs". *
CAS on line, QUESTEL, AN 098-119358 & Acta Pharm. Jugosl., Vol. 32, paginas 275-280, 1982. "Central mechanism of the antiarrhythmic action of benzodiazepines". *
Journal Pharm. Pharmacol., 1991, Vol. 43, paginas 879-881. J. HERNANDEZ. "The negative inotropic effect of diazepam in ret right ventricular strips". *

Also Published As

Publication number Publication date
ES2148057B1 (es) 2001-05-16

Similar Documents

Publication Publication Date Title
EP0209689A3 (en) Use of tetrahydrobiopterins in the treatment of infantile autism
HK1005985A1 (en) Combined use of hyaluronic acid and therapeutic agents to improve the therapeutic effect
NZ335981A (en) Ketobenzamides as calpain inhibitors
GB0005251D0 (en) Therapeutic compounds
GR3030751T3 (en) Peptidyl compounds and their therapeutic use as inhibitors of metalloproteases
MX9700538A (es) Uso de droloxifeno y sus sales farmaceuticamente aceptables en la preparacion de remedios para las enfermedades cardiovasculares.
MY138059A (en) Use of ikb-kinase inhibitors in pain therapy
EP0151989A3 (en) Means for the treatment of cardiac diseases
UA41355C2 (uk) Засіб для лікування нейро-сніду
MY164077A (en) Compositions and uses of et743 for treating cancer
HK1048308A1 (en) Novel compounds.
TW221445B (es)
MY133785A (en) Azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias
HUP9801924A2 (hu) Nátrium/hidrogén-csere inhibitorokat és szív- és keringési zavarok kezelésére alkalmas hatóanyagokat tartalmazó gyógyszerkészítmény
HK1029932A1 (en) Use of mirtazapine for the manufacture of a medicament for treating sleep apneas.
PL318130A1 (en) Terpenod derivatives (of sarcodictyine)as antineoplastic agents
EP0543902A4 (en) Use of metalloporphyrins to potentiate aids therapy
NZ503372A (en) Chemical supplementation of bone by exposing bone to a therapeutic compound and applying a potential difference across the bone or tissue
ES2148057A1 (es) Nuevo uso del diacepam como potenciador del efecto de los inhibidores pde 3
GB9626472D0 (en) New use of comt inhibitors
NZ335057A (en) Pentaerythritol derivatives, their production and use and intermediates for their synthesis
FI965171A (fi) Oksatsofosforiinien, esimerkiksi ifosfamidin, enantiomeerien käyttö kasvainten hoidossa sivuvaikutuksien vähentämiseksi
AU3742295A (en) Purine and 8-azapurine derivatives suitable to the therapeutic treatment of aids
MD980248A (ro) Derivaţi ai carbolinei
MXPA02004704A (es) Analogos de acido hidroxieicosatetraenoico y sus metodos de uso en el tratamiento de trastornos de resequedad del ojo.

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20001001

Kind code of ref document: A1

Effective date: 20001001

FD2A Announcement of lapse in spain

Effective date: 20180426